These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22040425)

  • 21. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire.
    Goldberg I; Clement CI; Chiang TH; Walt JG; Lee LJ; Graham S; Healey PR
    J Glaucoma; 2009 Jan; 18(1):6-12. PubMed ID: 19142128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study.
    Cedrone C; Mancino R; Ricci F; Cerulli A; Culasso F; Nucci C
    J Glaucoma; 2012 Jan; 21(1):1-6. PubMed ID: 21173704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the s-wave of multifocal electroretinograms in eyes with primary open-angle glaucoma.
    Kobayashi M; Tazawa Y; Haga-Sano M; Nabeshima T; Murai K
    Jpn J Ophthalmol; 2004; 48(3):208-14. PubMed ID: 15175911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
    Hudson HL; Lane SS; Heier JS; Stulting RD; Singerman L; Lichter PR; Sternberg P; Chang DF;
    Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between visual field loss in glaucoma and health-related quality-of-life.
    van Gestel A; Webers CA; Beckers HJ; van Dongen MC; Severens JL; Hendrikse F; Schouten JS
    Eye (Lond); 2010 Dec; 24(12):1759-69. PubMed ID: 21057519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Visual field progression after trabeculectomy in primary open-angle glaucoma: preliminary results].
    Dieng M; Wane A; Ba E; Roth PN; Demeideros M; Ndiaye M; Ndiaye P; Wade A
    J Fr Ophtalmol; 2009 Sep; 32(7):474-80. PubMed ID: 19596485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Color vision deficit in normal-tension glaucoma eyes.
    Yamagami J; Koseki N; Araie M
    Jpn J Ophthalmol; 1995; 39(4):384-9. PubMed ID: 8926646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foveal cone photoreceptor involvement in primary open-angle glaucoma.
    Kanis MJ; Lemij HG; Berendschot TT; van de Kraats J; van Norren D
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):999-1006. PubMed ID: 20213477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphology of the optic papilla in glaucoma. II. Secondary chronic open angle glaucoma].
    Budde WM; Jonas JB
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):221-7. PubMed ID: 10572883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK
    Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The selective effects of elevated intraocular pressure on temporal resolution.
    Lachenmayr BJ; Drance SM
    Ger J Ophthalmol; 1992; 1(1):26-31. PubMed ID: 1477614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glaucoma and quality of life: the Salisbury Eye Evaluation.
    Freeman EE; Muñoz B; West SK; Jampel HD; Friedman DS
    Ophthalmology; 2008 Feb; 115(2):233-8. PubMed ID: 17655930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma?
    Lamoureux EL; Ferraro JG; Pallant JF; Pesudovs K; Rees G; Keeffe JE
    Optom Vis Sci; 2007 Aug; 84(8):789-96. PubMed ID: 17700342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R; dos Santos LC; Vila MP; Magacho L
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glaucoma on the quality of life of young patients.
    Gupta V; Dutta P; OV M; Kapoor KS; Sihota R; Kumar G
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8433-7. PubMed ID: 21969294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma.
    Teus MA; Castejón MA; Calvo MA; Pérez-Salaíces P; Marcos A
    Ophthalmology; 1998 Dec; 105(12):2225-9; discussion 2229-30. PubMed ID: 9855151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse loss of sensitivity in early glaucoma.
    Henson DB; Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3147-51. PubMed ID: 10586936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.